SPX3,693.23-64.76 -1.72%
DIA295.86-4.66 -1.55%
IXIC10,867.93-198.88 -1.80%

LAVA Therapeutics Q2 EPS $(0.31), Same YoY, Sales $468.00K Down From $1.08M YoY

LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.31) per share. This is unchanged from the same period last year. The company reported $468.00 thousand in sales this quarter. This is a 56.71 percent

Benzinga · 09/13/2022 16:08
LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.31) per share. This is unchanged from the same period last year. The company reported $468.00 thousand in sales this quarter. This is a 56.71 percent decrease over sales of $1.08 million the same period last year.